Cartalax

Recovery

Cartalax

Short bioregulator peptide studied in relation to cartilage and connective tissue.

  • Third-party tested
  • EU shipping · discreet delivery, free over €459.99
  • Card, Apple Pay, Google Pay or crypto

Overview

Cartalax belongs to the short 'bioregulator' peptides developed in Russia by Khavinson's group, each associated with a specific tissue. Cartalax is linked to cartilage and connective tissue.

Most of the published research comes from cell and animal studies by the same research school, so independent data are limited.

Research areas

  • Cartilage and connective-tissue cells
  • Gene expression in ageing tissue
  • Bioregulator peptide research

Specifications

Category
Recovery
Compound
Synthetic tripeptide bioregulator (Ala-Glu-Asp)
Structure
3 amino acids
Form
Lyophilised (freeze-dried) powder in sealed vials
Available as
20mg (10 vials)
Quality
Third-party tested

Storage and handling

Unopened vials: freezer (−20 °C) for long-term storage, or refrigerator (2–8 °C) for shorter periods. Keep away from light and moisture. After reconstitution, keep refrigerated.

Sold strictly for laboratory research use only. Not for human consumption, and not intended to diagnose, treat, cure or prevent any disease.

More in Recovery